NCT02957786View on ClinicalTrials.gov

Cytisine Versus Varenicline for Smoking Cessation

PHASE3CompletedINTERVENTIONAL
Enrollment

679

Participants

Timeline

Start Date

September 18, 2017

Primary Completion Date

October 10, 2019

Study Completion Date

October 10, 2019

Conditions
Smoking Cessation
Interventions
DRUG

Cytisine

Cytisine tablets

BEHAVIORAL

Behavioural support

Withdrawal-orientated cessation support

DRUG

Varenicline

Varenicline tablets

Trial Locations (1)

1072

National Institute for Health Innovation, University of Auckland, Auckland

All Listed Sponsors
collaborator

Lakes District Health Board

OTHER

collaborator

Brunel University

OTHER

lead

University of Auckland, New Zealand

OTHER

NCT02957786 - Cytisine Versus Varenicline for Smoking Cessation | Biotech Hunter | Biotech Hunter